The team at i-sense have been working collaboratively across institutions to develop point-of-care diagnostic tests for COVID-19. When the UK went into lockdown in mid-March, a small group of researchers were given special access to i-sense labs in London and quickly implemented appropriate measures to ensure they could continue this important work safely.
Professor Molly Stevens’ team have been awarded £50,000 in funding from the new Imperial College COVID-19 Response Fund to develop point-of-care diagnostics for the current pandemic.
Led by Prof Molly Stevens, the i-sense team at Imperial College London have received over €500,000 in funding from the European Institute of Innovation and Technology (EIT) as part of their COVID-19 Rapid Response Call.
i-sense has received £500,000 in funding from the Engineering and Physical Research Council (EPSRC) to urgently assist with the response to the COVID-19 pandemic.
In response to the recent outbreak of the new coronavirus (COVID-19), i-sense researchers have been working collaboratively to rapidly adapt our tools and technologies to support development of emergency diagnostics and surveillance to assess the prevalence of the virus.
i-sense research into connected diagnostics was highlighted at the World Economic Forum this year by i-sense Deputy Director, Prof Molly Stevens.
Recent research from i-sense members at UCL seeks to understand whether currently available digital health technologies and online information related to HIV offers adequate emotional support.
A simple and sensitive test developed by i-sense engineers at Imperial College London, in collaboration with MIT, has produced a colour change in urine to signal growing tumours in mice.
In light of technology advances, a recent publication in Nature Microbiology, updates the current benchmark that describes the ideal diagnostic test, taking into consideration the need to achieve the Sustainable Devel
A recent study, published in Journal of Virological Methods, suggests and evaluates a modification to a currently used lab-based diagnostic test for dengue. The improved test has shown it can reduce the likelihood of false negatives and increase identification of a specific type of the virus.
